Human Health and Potential (HHP)

A*STAR researchers developed specially designed nanocomplexes that effectively target and kill cancer cells, including those resistant to traditional treatments.

Researchers use virtual simulations to track and predict how chemicals used in everyday objects impact human health over time.

Researchers develop a new technology for studying how brain tumours interact with the blood-brain barrier to inform future treatment strategies.

Researchers identify predictive immune ‘signatures’ in liver cancer patients that can help tailor and improve the success rates of combined immunotherapy and radiotherapy.

An innovative genomic approach speeds up the search for new fungal enzymes to sustainably create industrial products ranging from perfumes to jet fuel.

Researchers performed a comprehensive genetic sequencing of individual tumour cells to refine existing colorectal cancer classifications.

A*STAR researchers explore mushroom extracts as healthy fat substitutes to boost the nutritional profiles of meat products.

An experimental antibody therapy for solid tumours in adults also shows promise in improving quality of life for paediatric patients.

Research reveals that the way we chew can affect our blood sugar levels, offering improved strategies for managing blood sugar in people at risk for type 2 diabetes.

A polymer-based drug delivery innovation can replace invasive eye treatments for retinal diseases.

A*STAR researchers explore the potential and challenges associated with meat-free protein sources for a sustainable, healthier global diet.

A programmable gene editing tool targets and eliminates a rapidly mutating RNA virus responsible for hand, foot and mouth disease.